| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.9M | -44.9% |
| Cost of Revenue | $31.7M | -42.4% |
| R&D Expense | $49.8M | -34.4% |
| SG&A Expense | $35.2M | -44.0% |
| Operating Income | -$107.8M | +17.5% |
| Pre-tax Income | -$116.9M | -31.6% |
| Income Tax | $50K | +114.6% |
| Net Income | -$117.0M | -38.2% |
| EPS (Basic) | -$0.57 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.9M | +173.1% |
| Accounts Receivable | $3.6M | -74.1% |
| Inventory | $13.3M | -14.2% |
| Current Assets | $259.9M | +116.1% |
| Total Assets | $500.5M | +28.3% |
| Current Liabilities | $52.1M | +146.5% |
| Total Liabilities | $56.8M | +35.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.9M | +27.1% |
| Capital Expenditures | $1.5M | -78.2% |
| Investing Cash Flow | -$1.4M | +85.1% |
| Financing Cash Flow | $194.6M | +5469.1% |
| Free Cash Flow | -$44.4M | +32.4% |
| -23.9% |
| EPS (Diluted) | -$0.57 | -23.9% |
| Stockholders' Equity |
| $443.7M |
| +27.5% |